Trial intelligence / Profile preview

Slow vs fast injection of metoclopramide for akathisia in cancer patients

IRCT20170808035565N2Phase 2Completed

Sponsor
Mazandaran University of Medical Sciences
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of metoclopramide in akathisia and cancer (2 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoints: Mental restlessness and Motor restlessness (motionless rest). Started Jan 2018; status: completed.

02

Drugs

metoclopramide
03

Conditions

akathisiacancer

Beyond the preview

Go deeper on IRCT20170808035565N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20170808035565N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call